It has been reported that splenic immune responses play pivotal roles in the development of allergic diseases; however, the precise role of the spleen remains unclear. Herein, we demonstrated a novel role of the spleen in the pathogenesis of food allergy (FA). We found that mast cells (MCs) developed from progenitor cells present in spleen during an antigen-specific T-cell response in vitro. In a T h 2 response-mediated FA model, significant expansion of MCs was also observed in spleen. The incidence of allergic diarrhea was profoundly reduced in splenectomized mice, whereas adoptive transfer of in vitro-induced splenic MCs into these mice restored allergic symptoms, suggesting that the splenic MCs functioned as the pathogenic cells in the development of FA. The in vitro-generated MCs required not only IL-3 but also IFN-γ, and treatment of FA-induced mice with anti-IFN-γ antibody suppressed expansion of MCs in spleen as well as diarrhea development, highlighting that IFN-γ in the spleen orchestrated the development of FA, which was followed by a T h 2 response in the local lesion. Overall, we propose that the role of the spleen in the development of FA is to provide a unique site where antigen-specific T cells induce development of pathogenic MCs.
Introduction
Because of its increased prevalence (1, 2) , food allergy (FA) has become a major global health problem. FA is caused by an inappropriate specific immune response to certain foods, e.g. peanut, milk or egg (2, 3) , and this response leads to several allergic symptoms such as urticaria, diarrhea and, in extreme cases, anaphylaxis (4, 5) . These clinical outcomes lead to impairment in the quality of life for the affected individuals and can sometimes be fatal. To establish effective and safe FA treatments, many efforts have been made to clarify the mechanisms responsible for specific clinical manifestations, which remain incompletely understood. In order to help solve this problem, we and other groups have established animal models of FA (6) (7) (8) (9) . We have previously reported that mice systemically primed with ovalbumin (OVA)/CFA and then repeatedly challenged orally with OVA developed severe diarrhea. In these mice, there was a dramatic infiltration of mast cells (MCs) in the intestines (6, 10) . Using a similar animal model, another group showed that mice treated with anti-c-Kit mAb or anti-IgE mAb, or with a targeted deletion of FcεRI, were impaired in the development of diarrhea after oral administration of OVA (7, 11) , indicating that MCs play a critical effector role in mediating allergic diarrhea.
Using these animal models, the role of T cells in FA has also been intensively studied. We have shown that CD4 + T cells are preferentially recruited into the large intestine (LI) and produced IL-4 and IL-13 upon exposure to orally administered OVA, and that Stat6 gene-targeted mice failed to develop OVA-induced diarrhea (6) . Together with the fact that systemically sensitized nude mice or STAT6-deficient mice did not show any sign of allergic responses following OVA challenge, we proposed that induction of allergic diarrhea required migration and activation of mucosal MCs mediated by type 2 T-cell responses. The incidence of allergic diarrhea was profoundly reduced in splenectomized mice (10) , suggesting that spleen plays a critical role in the induction of intestinal allergic responses. Since it has been reported that the spleen is involved in the development of other allergic diseases (12), we sought to define which cells in spleen were involved and how they cause allergic reactions in the intestine.
In this work, we demonstrated that repeated in vitro stimulation of spleen cells from OVA/CFA-immunized mice with OVA peptide led to the preferential development of MC lineage cell populations. These MCs developed from hematopoietic stem and progenitor cells (HSPCs) present in spleen and had some unique features that differed from bone marrowderived mast cells (BMMCs) in terms of intracellular granules and the expression pattern of mast cell proteases (Mcpts). Interestingly, the development of these MCs required not only IL-3 but also IFN-γ. Consistent with these in vitro studies, in our animal model of FA, there was significant expansion of an MC population in spleen, in addition to that previously noted in the LI. Treatment of mice with anti-IFN-γ antibody suppressed diarrhea development as well as expansion of MCs in spleen, suggesting that IFN-γ-dependent splenic MCs played a crucial role in the induction of T h 2 response-dependent FA. Consistent with this hypothesis, adoptive transfer of purified in vitro-induced splenic MCs restored the allergic diarrhea in splenectomized mice. Overall, our observations suggest that the spleen plays an important role in this intestinal allergic disorder as the site where pathogenic MCs develop during food antigen-specific T-cell responses.
Methods

Antibodies and reagents
Fluorescent dye-or biotin-conjugated antibodies. PECy7-or BV421-anti-mouse CD3 antibody (17A2), PE-anti-mouse B220 antibody (RA3-6B2), FITC-or PE-anti-mouse FcεRIα antibody (MAR-1), PE-anti-mouse IL3Rα antibody (5B11), APC-or PE-anti-mouse c-Kit antibody (2B8) and PECy7-streptavidin were purchased from Biolegend (San Diego, CA, USA). Biotin-anti-mouse Gr-1 antibody (RB6-8C5), anti-mouse NK1.1 antibody (PK136) and FITC-anti-mouse B220 antibody (RA3-6B2) were purchased from BD Pharmingen (San Jose, CA, USA). Biotin-anti-mouse CD11c antibody (N418), anti-mouse Ter-119 antibody (TER119), anti-mouse CD11b antibody (M1/70), anti-mouse FcεRIα antibody (MAR-1), APC-anti-mouse Sca-1 antibody (D7) and FITC-anti-5-Bromo-2′-deoxyuridine (BrdU) antibody (Bu20a) were purchased from eBioscience (San Diego, CA, USA). Biotin-anti-mouse CD3 antibody (7D6) was prepared in our laboratory.
Neutralizing antibody against cytokines. Anti-mouse IL-3 antibody (MP28F8) and anti-mouse IL-4 antibody (AB-404-NA) were purchased from R&D Systems (Minneapolis, MN, USA). Anti-mouse IL-2 antibody (S4B6), anti-mouse IFN-γ antibody (R4) and anti-mouse IL-4 antibody (11B11) were prepared in our laboratory.
Complete medium. RPMI 1640 was supplemented with 10% FCS, 10 mM HEPES (pH 7.4), 0.1 mM non-essential amino acid solution, 1 mM sodium pyruvate (GIBCO, Waltham, MA, USA), 2 mM l-glutamine (Wako, Osaka, Japan), penicillin and streptomycin.
Mice
BALB/c mice were purchased from Sankyo Labo Service (Tokyo, Japan). All animals were maintained under specific pathogen-free conditions in the Tokyo University of Science (TUS). All animal protocols were approved by the TUS Animal Care and Use Committee (S16012, S15001 and S14001) and were performed in accordance with the relevant guidelines.
Cell culture
For the splenocyte or lymph node (LN) cell cultures, 6-14-weekold female BALB/c mice were subcutaneously immunized with 5 µM OVA 323-329 peptides (OVAp), which were synthesized at Eurofins Genomics (Tokyo, Japan), emulsified in 100 µl of CFA (Difco, Detroit, MI, USA). After 1-3 weeks, the spleen and the inguinal LNs were removed from the mice and homogenized. Splenocytes or LN cells (5 × 10 6 cells per well) were cultured in 24-well plates for 1 week in the presence of 250 nM OVAp in complete medium. After 1 week of primary culture, the cells were collected by lymphocyte separation media (MP Biomedicals, Santa Ana, CA, USA). Viable cells (5 × 10 5 cells per well) were put into 24-well plates and re-stimulated with 30 Gy-irradiated splenocytes (5 × 10 6 cells per well) from BALB/c mice as antigen-presenting cells and the same concentration of OVAp. These procedures were repeated every week.
For the analysis of cytokine profiles of the splenocyte culture, culture supernatants were collected every week and subjected to Multiplex Assays (Merck Millipore, Darmstadt, Germany) performed according to the manufacturer's protocol.
For the in vitro neutralizing antibody (NAb) treatment, anti-IL-2 mAb (S4B6, 30 µg ml ) or PBS (as a control) were added into the splenocyte cultures every week from primary culture to 3 weeks.
For the induction of BMMCs, cells were prepared from bone marrow (BM) of BALB/c mice and cultured with 10 ng ml −1 recombinant IL-3 [prepared from a mouse IL-3-producing cell line, BCMGS-mIL-3-transfected P3V1, kindly provided by Dr Karasuyama (Tokyo Medical and Dental University, Tokyo, Japan (13) For sorting, cells in the splenocyte cultures at 3 weeks and BMMCs were harvested. After Fc blocking, they were stained with fluorescent-conjugated mAb specific for FcεRIα and c-Kit, and TCMCs (T-cell-inducible MCs) and BMMCs (FcεRIα + c-Kit + ) were sorted. For LSK or MP sorting, splenocytes were prepared from OVA-immunized mice. After Fc blocking, they were first stained with a cocktail of biotin-conjugated lineage mAbs (CD3, B220, CD11c, Gr-1, Nk1.1, CD11b and Ter-119) and PECy5-conjugated streptavidin. Then, the cells were stained with PE-conjugated c-Kit and APC-conjugated Sca-1. LSK and MP were sorted using a FACSAria II (BD).
Microarray analysis
Total RNA was collected from purified TCMCs and BMMCs using an RNeasy Kit (QIAGEN). The microarray analysis was performed by MBL (Nagoya, Japan) and the data were analyzed using GenePattern (14) .
Allergic diarrhea induction and NAb treatment
The induction of allergic diarrhea and the treatment with NAb was previously described (6) . In brief, for the induction of the allergic diarrhea, 5-9-week-old BALB/c mice were subcutaneously immunized with 1 mg of OVA (Grade V; Sigma-Aldrich) emulsified in 100 µl of CFA. After 1 week, the mice were fed 50 mg OVA in 300 µl PBS by feeding needles (Natsume Seisakusho CO., Ltd., Tokyo, Japan) three times a week.
For the in vivo NAb treatment, rat anti-mouse IFN-γ mAb (R4, 1 mg per mouse), rat anti-mouse IL-4 antibody (11B11, 1 mg per mouse) or PBS (as control) were intra-peritoneally administrated starting 1 week before the immunization with OVA/CFA. The NAb treatment was continued once a week throughout the course of the experiment.
Splenectomy and adoptive transfer
Splenectomy was performed as previously described (10) . One week after the spleen was removed from BALB/c mice, sham-operated or splenectomized mice were subject to treatment for the induction of allergic diarrhea.
For adoptive cell transfer, T cells in the 3-week splenocyte cultures were depleted by anti-Thy1.2 mAb (HO-13-4) plus complement (see Supplementary Methods, available at International Immunology Online). The purity of in vitro-generated TCMCs was >90% (Supplementary Figure 1 , available at International Immunology Online). One day after the sixth oral challenge with OVA, purified TCMCs (5 × 10 6 cells per mouse) or BMMCs (5 × 10 6 cells per mouse) or PBS were injected via the tail vein into splenectomized mice that had failed to develop allergic diarrhea. One week after these transfers, oral challenge with OVA was resumed. Shamoperated mice with immunization or splenectomized mice without immunization were given OVA orally and used as positive and negative controls, respectively.
Cell isolation
For the preparation of lamina propria leukocytes (LPLs), LIs were removed from each treated mouse. After washing with PBS, LIs were dissected into 1-2 cm pieces and agitated at 37°C for 20 min in pre-warmed PBS containing 5 mM EDTA (Sigma-Aldrich) and 0.145 ng ml −1 DL-dithiothreitol (SigmaAldrich). The dissected LIs were collected and actively shaken twice in pre-warmed EDTA containing PBS and then were incubated in pre-warmed RPMI 1640 containing 5% calf serum (CS) at 37°C for 20 min and collected followed by two rounds of active shaking. Then, the LI segments were agitated at 37°C for 20 min in pre-warmed RPMI 1640 containing 1 mg ml −1 collagenase D (Roche), 0.5 mg ml −1 Dispase (GIBCO) and 0.3 mg ml −1 DNase I (Sigma-Aldrich) three times. LPLs were then obtained from 40/80% percoll (GE Healthcare) gradients. The collected cells were washed twice in RPMI 1640 containing 5 % CS and suspended in complete medium.
Statistical analysis
Statistical analysis was performed using Prism6 (GraphPad Software, San Diego, CA, USA). Significance was determined by a two-way ANOVA and Sidak's multiple comparisons test (Figs 2C and D, 3B and C, 5C, D, and F and 7A), a one-way ANOVA and Dunnett's test (Fig. 3A) , an unpaired Student's t-test (Figs 5B and 7D and E), a one-way ANOVA and Tukey's multiple comparisons test (Figs 5E and 6B). A P value <0.05 was considered significant.
Results
An increase in splenic MCs accompanies antigen-specific T-cell responses in vitro
To establish OVA-reactive T cell lines, splenocytes and LN cells from BALB/c mice immunized with OVA/CFA were repeatedly re-stimulated with OVA in vitro. Unexpectedly, we found that the proportion of T cells in the spleen cultures gradually decreased beginning ~2 weeks after the initial antigen stimulation. Instead of T cells, CD3 − B220 − cells [non-T, non-B (NTNB) cells] began to increase and became the predominant population at 3 weeks (Fig. 1A , upper panels). The proliferation of the splenic T cells was enhanced by OVA stimulation, indicating that the increase of NTNB cells in these cultures was not simply due to the inability of the T cells to proliferate (Fig. 1B) . In marked contrast to splenocytes, stimulation of LN cells with OVA increased the proportion of T cells but not NTNB cells (Fig. 1A , lower panels). These results indicated that NTNB cells among splenocytes were expanded following the activation of T cells, but that this expansion did not occur with LN cells.
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We next investigated the changes in cell populations in splenocyte cultures over time. Gr-1 + CD11b + cells and FcεRIα + c-Kit − cells were detected until 2 weeks but had disappeared by 3 weeks (Fig. 1C) . On the other hand, FcεRIα + c-Kit + cells gradually increased from 2 weeks and become the major population at 3 weeks ( Fig. 1C and D) . FcεRIα + c-Kit + cells Table 1) . These results are representative data of more than two independent experiments. are generally considered to be MCs, so to explore that possibility, MC/basophil fate-related genes were analyzed by RT-PCR. GATA-1, PU.1 and MITF, but not C/EBPα, were highly expressed by the FcεRIα + c-Kit + cells, an expression pattern similar to that of IL-3-elicited BMMCs (Fig. 1E ). These data suggested that antigen-specific T-cell responses increased MC numbers in splenocyte cultures, thus we referred to these MCs as TCMCs.
The antigen-specific T-cell response confers unique features on TCMCs
We next investigated the features of in vitro-generated TCMCs. Morphological analysis by electron microscopy showed that the TCMCs, like BMMCs, had a round nucleus but that their cytosolic granules were smaller and less abundant than those in BMMCs ( Fig. 2A, upper panels) , although a strong metachromatic reaction with toluidine was observed in both types of MCs ( Fig. 2A, lower panels) . Next, we used RT-PCR to compare the expression of Mcpts in TCMCs and BMMCs. Mcpt-5 and 6 expression was similar, whereas that of Mcpt-2 and 4 was much higher in TCMCs. Interestingly, unlike BMMCs, the TCMCs expressed Mcpt-8 ( Fig. 2B) , which is specifically expressed only in basophils (15) . To begin to examine the functional activities of TCMCs, we first performed a β-hexosaminidase release assay and found that degranulation of TCMCs could be induced by stimulation with anti-DNP IgE + DNP-BSA (Fig. 2C, left) , and that the total content of β-hexosaminidases was the same in both types of MCs (Fig. 2C, right) . In the same assay, IL-4 and -6 were produced by both TCMCs and BMMCs; however, unlike BMMCs, TCMCs secreted IFN-γ in response to PMA/ Ionomycin (Fig. 2D) . These results indicated that TCMCs could respond to stimulation by IgE and antigen like BMMCs, but that they also had some unique features.
To dissect the phenotypic differences between TCMCs and BMMCs in greater detail, we performed microarray analysis. We found that the expression patterns of several cell surface molecules ( 
IFN-γ facilitates the increase of TCMCs by modulating their expression of the IL3R
To dissect the environment in which TCMCs were so dramatically expanded, we measured cytokines in the culture supernatants. IL-3, which is an important cytokine for BMMC development and growth (16) , was detected at week 1 and 2, but not at week 3 (Table 1) . A large amount of IFN-γ was present in the culture supernatants at all time points tested, whereas IL-4 and IL-13 were hardly detected at any point (Table 1) . To investigate whether any of these cytokines influenced the growth of TCMCs, we inhibited each of them with NAb. As expected, the neutralization of IL-3 abrogated the increase of TCMCs (Fig. 3A) , indicating that IL-3 was essential for their growth, as it is for BMMCs. Treatment with anti-IL-4 antibody had no effect but, unexpectedly, the neutralization of IFN-γ also inhibited the increase of TCMC (Fig. 3A) . These data suggested that IFN-γ might support the IL-3-mediated increase of TCMCs. IFN-γ increases the expression of MHC class II on antigen-presenting cells, leading to an enhancement of T-cell activation (17) . Therefore, we hypothesized that stimulation with IFN-γ might facilitate the production of IL-3 by T cells, leading to expansion of the TCMCs. To test this hypothesis, we evaluated whether IL-3 production by T cells was affected by neutralization of IFN-γ but found no effect when assayed at 3 weeks (Fig. 3B) . Another possibility was that IFN-γ might instead affect the sensitivity of TCMCs to IL-3 by modulating their expression of the IL3R. Indeed, neutralization of IFN-γ significantly reduced the frequency of IL3R + TCMCs at 3 weeks after stimulation of the T cells with OVA (Fig. 3C ). IL-3 in culture supernatants was hardly detected at 3 weeks (Table 1) , although splenic T cells could produce IL-3. We propose that the loss of IL-3 in the culture supernatants was due to its consumption by IL3R + TCMCs. Therefore, these results suggest a model in which IFN-γ promotes the expression of the IL-3R on TCMCs, leading to their remarkable expansion through IL3-IL3R signaling.
Antigen-specific T-cell responses induce not only MC expansion but also their differentiation from splenocytes
Antigen-specific T-cell responses resulted in expansion of MCs in cultures of splenocytes but not LN cells (Fig. 1) . HSPCs from BM have been reported to be present in spleen but not LNs (18 , which contain common myeloid progenitors and granulocyte-macrophage progenitors, were observed in spleen (Fig. 4A , left panels), but were barely detectable among LN cells (Fig. 4A, right panels) . On the basis of these observations, we hypothesized that the antigen-specific T-cell responses influenced the differentiation of these HSPCs into MCs in spleen. To test this hypothesis, we purified LSK and MP from spleen and then co-cultured them with T cells derived from the spleens of OVA-immunized mice. TCMCs were predominant at 3 weeks in the LSK and MP cultures after repeated stimulation of the T cells with OVA ( Fig. 4B and  C) . Collectively, these data suggested that T-cell responses elicited by antigen led to the differentiation of splenic HSPCs into TCMCs.
Splenic TCMCs contribute to the development of allergic diarrhea
We have previously reported that BALB/c mice primed systemically with OVA/CFA developed severe diarrhea after repeated oral administration of OVA (Fig. 5A) (6) . In this FA animal model, MC-deficient c-Kit W-sh/W-sh mice failed to develop allergic diarrhea (Supplementary Figure 3 , available at International Immunology Online), indicating a crucial role for MCs in its pathogenesis. Flow cytometry analysis revealed that the number of MCs in LI significantly increased after the development of diarrhea (Fig. 5B) , confirming the massive infiltration of MCs into the LI previously shown by histological analysis (6) . In addition, we observed a significant increase in splenic MCs in the FA mice (Fig. 5B) . On the basis of these observations, we focused on the relationship between splenic MCs and the intestinal allergic reaction in this FA animal model. Unlike MCs in LI, which increased only after oral administration of OVA and the allergic diarrhea onset (Fig. 5C) , the marked increase in splenic MCs was observed at 1 week after OVA/CFA immunization before the onset diarrhea (Fig. 5D ) and this was not observed in PBS/CFA-immunized mice (Fig. 5E ). These results indicated that the increase of MCs in spleen was not due to some non-specific adjuvant effect of CFA, but rather to antigen-specific T-cell responsedependent effects and, therefore, the MCs in spleen may be equivalent to the splenic TCMCs induced in in vitro.
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The number of MCs in spleen tended to decrease after oral administration of OVA (Fig. 5D) , suggesting that the MCs either expired in situ or migrated out of the spleen. We therefore examined the frequency of MCs among peripheral blood lymphocyte (PBL) after oral challenge and found that there was a sharp increase up to three oral challenges and then a decrease after that (Fig. 5F ). These results are consistent with the idea that after oral OVA challenge, MCs leave the spleen, enter the bloodstream and migrate into the LI, where they contribute to FA pathogenesis.
In a previous report, based on the observation that the incidence of allergic diarrhea was reduced in splenectomized mice, we proposed that the spleen is an essential site for the induction and establishment of intestinal allergic responses (10) . To examine whether splenic MCs contributed to the development of FA, we induced the allergic diarrhea in splenectomized mice. Consistent with our previous report (10), splenectomy suppressed allergic diarrhea development (Fig. 6A) . We also found a reduction in the proportion and the number of MCs in LI of splenectomized mice (Fig. 6B) . To determine whether the loss of splenic MCs was simply due to the inability of splenectomized mice to develop the allergic symptoms, we transferred purified in vitro-induced TCMCs (Supplementary Figure 1 , available at International Immunology Online) into OVA-challenged splenectomized mice. The transfer of these TCMCs, but not BMMCs, restored the development of allergic diarrhea ( Fig. 6C and D) . Taken together, these results suggested that splenic MCs acted as the effector cells in the pathogenesis of FA.
IFN-γ is required for the increase of splenic MC in the development of T h 2 response-mediated allergic diarrhea
We showed in vitro that IFN-γ was required for the increase of splenic TCMCs through its enhancement of IL3-IL3R signaling (Fig. 3) . To investigate whether IFN-γ also contributed to the increase of splenic MCs in vivo, first, we examined the cytokine profile of splenic T cells at the sensitization phase and found that IL-3 and IFN-γ, but not IL-4, were produced by splenocytes of OVA/CFA-immunized mice after stimulation with OVA (Fig. 7A) . On the other hand, at the onset of the diarrhea, IL-4 mRNA was up-regulated in both LI-LPL (Fig. 7B , left panels) and spleen (Fig. 7B, right panels) . Neutralization of IL-4 prevented the allergic diarrhea (Fig. 7C) indicating that, indeed, T h 2-mediated immune responses in both LI and spleen play a crucial role in developing allergic symptoms. Since splenic TCMCs functioned in the development of the allergic diarrhea (Fig. 6C ) and IFN-γ was required for the increase of splenic TCMCs (Fig. 3A) , we investigated whether IFN-γ contributed to disease pathogenesis. As shown in + TCMCs in untreated or anti-IFN-γ Ab-treated cultures at the indicated points is shown (n = 3). Data are mean + SEM. Significance was determined by a two-way ANOVA and Sidak's multiple comparisons test. *P < 0.05, **P < 0.01, n.s., not significant; n.d., not detected. 
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Fig . 7(C) , administration of IFN-γ NAbs strongly inhibited the incidence of diarrhea. Flow cytometry analysis revealed that neutralization of IFN-γ significantly reduced the frequency of MCs both in spleen and in LI (Fig. 7D) and, similar to our in vitro observation, this treatment reduced IL3R + MCs in spleen as well (Fig. 7E) . Collectively, these results suggested that IFN-γ plays an important role in facilitating the increase of MCs in spleen through the enhancement of IL3R expression, and that both IFN-γ produced in spleen by food antigen-specific T-cell responses and T h 2-immune responses in the local lesion orchestrate the pathogenesis of this intestinal allergic disorder.
Discussion
In the present study, we have demonstrated a novel role for the spleen in the pathogenesis of FA. An antigen-specific T-cell response in vitro induced the development of a unique lineage of MC cells, the TCMCs, from HPSCs present in spleen. These TCMCs had features distinct from BMMCs in their morphology and cytokine production profile. Their development requirements were also unique; unlike BMMCs, which only needed IL-3 to develop from BM precursors. TCMCs required not only IL-3 but also IFN-γ. Mechanistically, we showed that IFN-γ up-regulated the expression of the IL3R on TCMCs, leading to the promotion of the IL3/IL3R-mediated development of these cells. Similar to these in vitro observations, a food antigen-specific T-cell response in vivo increased MC numbers in spleens of the FA-induced mice. We have previously reported that the development of allergic diarrhea in this model could be abrogated by splenectomy (10) . The adoptive transfer of in vitro-generated TCMCs showed that the inhibition of allergic diarrhea development in splenectomized mice was due to the loss of splenic MCs that develop during food antigen-specific T-cell responses induced systemically. The neutralization of IFN-γ, which inhibited the expansion of splenic TCMC in vitro, reduced the number of MCs in spleen and abrogated the development of diarrhea in our FA animal model. On the basis of these observations, we propose that the spleen functions as the site where food antigen-specific T-cell responses induce the development of pathogenic MCs in T h 2-imune response-mediated FA, and that IFN-γ plays a crucial role in their development.
We and other groups (7, 19, 20) have observed increases of MCs within the intestine of FA-onset mice ( Fig. 5B and C) (6) . Furthermore, we observed that MCs increased in spleen after OVA/CFA immunization and subsequently increased in PBL and LI of FA-induced mice (Fig. 5C-E) . Kasugai et al. (21) have reported that MCs or MC progenitors migrate from blood into the intestine during Nippostrongylus brasiliensis infection. Also, Parmentier et al. (22) showed that spleen acts as the reservoir of MCs in parasite-infected mice. From these reports (21, 22) and our available data, we originally thought that MCs expanded in LI were TCMCs of spleen origin. To test this hypothesis, we transferred in vitro-generated TCMCs from DsRed Tg mice into splenectomized mice. Although the development of diarrhea was restored in splenectomized mice, interestingly and importantly, we found that the expanded MCs in LI were negative for DsRed (data not shown), implying that splenic MCs do not directly migrate into LI and locally expand in this murine FA model. Although where MCs induced in spleen go and how they function remains undefined, it is possible that they are recruited into an MC survival niche where they may support (A) The graph shows the incidence of allergic diarrhea within 1 h after oral challenge with OVA (n = 18). (B) BALB/c mice were subject to the treatment to induce allergic diarrhea. Within 1 h after the 10th oral challenge, Ctrl or diarrhea-onset mice were sacrificed and analyzed. The representative flow cytometric plots (left) and the number (right) of MCs in both LI and spleen are shown (n = 7). Significance was determined by an unpaired Student's t-test. (C,D) The graph shows the kinetics of MC number in LI (C) and spleen (D) at the indicated time points (n ≥ 5 per group per three independent experiments). (E) One week after BALB/c mice were immunized without or with OVA/CFA or PBS/CFA, mice in each group were analyzed (n = 4-5). (F) The graph shows the frequency of MCs in PBL at the indicated time points (n ≥ 5 per group per three independent experiments). Data are mean ± SEM. Significance was determined by a two-way ANOVA and Sidak's multiple comparisons test (C,D,F) or by a one-way ANOVA and Tukey's multiple comparisons test (E). *P < 0.05, **P < 0.01, n.s., not significant. MC expansion in LI through enhancing T h 2 responses to ingested antigen. Indeed, IL-4 from MCs has been shown to promote food antigen-specific T h 2 responses (9, 23). The detailed mechanisms by which splenic MCs induce MC expansion in LI and contribute to the pathogenesis of FA are under investigation.
Our results indicated that the reconstitution of TCMCs but not BMMCs restored the development of FA (Fig. 6C and D) . Microarray and flow cytometric data indicated that TCMCs but not IL-3-induced BMMCs expressed MHC class II (Fig. 2E and Supplementary Figure 2 , available at International Immunology Online). Several studies have shown that (C) The graph shows the incidence of allergic diarrhea within 1 h after oral challenge in sham mice, TCMC-, BMMC-, PBS-transferred splenectomized mice and splenectomized mice without OVA/CFA immunization (n = 9-11 per group per three independent experiments). Based on the incidence of diarrhea after the 15th oral challenge, significance was determined by χ 2 test. (D) Representative images of the indicated mice. **P < 0.01, n.s., not significant.
MCs can activate effector CD4
+ T cells through TCR-MHC class II interactions (24) (25) (26) . Also, we showed that TCMCs release IL-4 in response to cross-linking of FcεRI (Fig. 2D) .
Thus, these data suggest that, in addition to IL-4 production, splenic MCs may enhance T h 2 responses through TCR-MHC class II interactions. Table 1 ). (C) The graph shows the incidence of allergic diarrhea within 1 h after oral challenge with OVA in PBS (n = 9)-, anti-IFN-γ Ab (n = 10)-and anti-IL-4 Ab (n = 3)-treated mice (three independent experiments). Based on the incidence of diarrhea after the 10th oral challenge, significance was determined by χ 2 test. (D,E) The number of MCs (D) and the frequency of IL3R-expressing MCs (E) in spleen (left) and MNCs of LI-LPL (right) from each group after the 10th oral challenge with OVA are shown. Data are represented as points for individual mice and the bars indicate mean ± SEM. Significance was determined by an unpaired Student's t-test. *P < 0.05, **P < 0.01, n.s., not significant; n.d., not detected.
We showed that TCMCs possessed unique features that were different from BMMCs. Especially, the expression of Mcpt-8 was unexpected (Fig. 2B) , since it is thought that this protease is specific marker for basophils (15) . In addition, it is known that progenitor cells that have the potential to differentiate into MCs and basophiles exist in spleen [e.g. basophil/MC progenitors (BMCPs) (27) ]. Thus, we assumed that in vitro-induced TCMCs were cells with the potential to differentiate into both MCs and basophils. It has been shown that BMCPs express MITF and C/EBPα (27) , which determine MC and basophil differentiation fates (28) . On the other hand, TCMCs expressed MITF but not C/EBPα (Fig. 1E) . These data indicate that in vitro TCMCs are committed to the MC lineage rather than being bipotential basophil/MC progenitors.
MCs are categorized as mucosal MCs (MMCs) and connective tissue MCs (CTMCs) on the basis of their localization (29, 30 (Fig. 2B ). These reports (29, 31, 32) , together with our current findings, suggest that TCMCs may be heterogeneous populations containing MMCs and CTMCs.
It has been reported that MCs increase in spleen under inflammatory conditions such as parasite infection (22, 33, 34) and chronic allergic dermatitis (12) . Those splenic MCs were characterized as having small hypogranules and round nuclei (34) and were capable of producing several cytokines, such as IL-4 and IL-6, in response to IgE plus cross-linking antigen (12, 34) . These reported features of splenic MCs were similar to those of TCMCs found in vitro ( Fig. 2A and  D) . Thus, these data suggest that the features and functions of in vitro-generated TCMCs resemble splenic MCs induced under inflammatory conditions.
It is well established that IL-3 is a common essential factor for the development of MCs from spleen and BM both in vitro and in vivo (16, 33, 35) . In addition, it is known that IFN-γ influences the development of splenic MCs. In contrast to IL-3, IFN-γ enhances in vitro MC development from splenocytes (36) but suppresses their development from BM cells (37) . We found that the blockade of IFN-γ inhibited the development of MCs from splenocytes in vitro (Fig. 3A) and reduced the number of MCs in spleens of the FA-induced mice (Fig. 7D) . Consistent with our results, Hu et al. (36) have also reported that IFN-γ is required for the development of splenic MCs in vitro. However, it has not been clarified until now how IFN-γ affects the development of splenic MCs. In this study, we demonstrated that the blockade of IFN-γ reduced the expression of the IL3R on splenic MCs in vitro (Fig. 3C) and in vivo (Fig. 7G) . On the basis of these results, we would propose that IFN-γ up-regulates the expression of the IL3R on splenic MCs, promoting IL-3-mediated signaling and leading to their expansion. Further experiments are required to dissect the precise mechanism by which IFN-γ controls IL3R expression on splenic MCs.
Seo et al. (38) showed that expression of cytokines such as IL-4, IL-6 and TNF-α in BMMCs was enhanced by IFN-γ stimulation. Also, IFN-γ promotes histamine release from BMMCs (39) . In this study, our data indicated that IFN-γ affected the induction of TCMCs in vitro (Fig. 3) and that cytokine production by these cells was higher than by BMMCs (Fig. 2D) . From these results, one could speculate that IFN-γ may convert BMMCs to TCMCs. However, it was reported that IFN-γ alone does not up-regulate MHC class II on BMMCs (25) . Also, the expression of Mcpts is regulated by several cytokines (40) (41) (42) . We found that the expression pattern of MHC class II and Mcpts in TCMCs was distinct from BMMCs ( Fig. 2B and E and Supplementary Figure 2 , available at International Immunology Online). Collectively, these results suggest that IFN-γ plus IL-3 stimulation may not be sufficient for BMMCs to acquire TCMC-like functions and phenotype. It is known that, in addition to cytokines, lipid mediators (43), cell-cell interactions (44, 45) and ATP (46, 47) have an influence on MC functions and phenotypes. Therefore, identification of factors conferring TCMC-like functions and phenotypes on BMMCs is a current area of investigation.
It is known that IL-3 is produced by T cells (48, 49) , MCs and basophils (50) . Several cell types, such as activated T cells (17) , NK cells (51) Fig. 7(A) showed that IL-3 and IFN-γ production by splenocytes of these mice were dependent on OVA stimulation ex vivo. Thus, our data suggested that OVA-reactive T cells functioned as the main source of these cytokines in response to food antigen.
The spleen plays an important role as one of the tissues where antigen-specific T-cell responses and antibody production by B cells take place, leading to systemic immune responses (53) . Also, spleen serves as a niche for HSPCs, including hematopoietic stem cells and common myeloid progenitors, which have the potential to differentiate into several types of myeloid cell lineages, including MCs and granulocytes (54) . The accumulation and differentiation of these HSPCs has been observed in spleens of mice with T-cell-mediated chronic colitis (55) . Also, Ahern et al. (56) demonstrated that activated T cells were increased in the spleen of the same animal model. These reports suggest that antigen-specific T-cell responses can have effects on the expansion and differentiation of HSPCs in spleen during a T-cell-mediated disease. In this study, we showed that antigen-specific T-cell responses led to the differentiation of splenic HSPCs into MCs in vitro (Fig. 4) and to the increase of MCs in spleen of the allergic diarrhea-induced mice (Fig. 5E ). These finding thus suggest that T-cell responses could induce the differentiation of HSPCs into MCs in spleen under appropriate allergic/inflammatory conditions. It is suggested that residential MCs function as effector cells in the development of FA (9, 57) . Also, a recent report demonstrated that MC progenitor cells which were supplied from BM during FA contributed to the progression of symptoms (20) . In addition to these cells, our data highlighted that MCs induced in spleen also play a crucial role in the allergic diarrhea development (Fig. 6C and D) . These observations suggest that FA is induced by the cooperation of several kinds of MCs rather than one specific MC.
Several studies have shown that the allergen-specific T h 2 responses are crucial for the pathogenesis of FA (6, 7, 9) and that IL-4 has a positive effect on MCs (58, 59) . Since IFN-γ inhibits T h 2 differentiation (60, 61) , it is thought that blocking of IFN-γ can accelerate T h 2 responses, leading to serious allergic inflammation. However, we clearly demonstrated here that the neutralization of IFN-γ significantly suppressed the pathogenesis of a T h 2 immune response-mediated FA (Fig. 7C) and reduced the number of MCs in both spleen and LI (Fig. 7D) , suggesting that IFN-γ plays a critical role in the pathogenesis of FA through increasing pathogenic MCs. Similar to our observation, Galli et al. revealed that IFN-γ had a key role in the development of MC-dependent chronic airway inflammation through activating of MCs (39, 62) . In addition to these murine allergic models, it has been reported that the secretion of IFN-γ by PBMCs of egg-and milk-allergic children is higher than that of the egg-and milktolerant children (63, 64) . These reports (63, 64) , together with our experimental findings, indicate that IFN-γ may induce the increase of splenic MCs, leading to the development of diarrhea in FA patients, similar to our findings in the murine FA model.
It has been reported that T cells of some FA patients produce IL-4 and IL-13, but not IFN-γ (65, 66) and that T cells of other FA patients secrete IL-4 and IFN-γ (63, 64). These reports suggest that different pathogenic mechanisms of FA may exist. In the murine FA model using OVA/Alum, IL-4 but not IFN-γ was increased in spleen (67) . This type of FA was not inhibited by splenectomy (data not shown). On the other hand, in our FA model using OVA/CFA, IL-4 and IFN-γ were increased in spleen (Fig. 7B) (6) and this FA was suppressed by splenectomy (Fig. 6A) (10) . On the basis of these observations, we hypothesize that there is a relationship between the cytokine production pattern in the spleen and the requirement for the spleen in the development of FA. Under circumstances where IL-4 but not IFN-γ contributes to FA, the spleen may be dispensable, whereas it may be essential under conditions in which both IL-4 and IFN-γ are involved in FA.
In conclusion, spleen is the site where pathogenic MCs develop during food antigen-specific T-cell responses at the early phase of the immune response to food. In spleen, IFN-γ from food antigen-specific T cells modulates the expression of IL3R on pathogenic MCs, which contributes to their IL3-mediated expansion in the pathogenesis of allergic diarrhea. Hence, we propose that interrupting the development of pathogenic MCs by T cells in spleen may protect us from life-threatening allergic reactions.
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